TIMER analysis showed the AKR1B10 expression was associated with multiple immune cells, especially CD4+ T cell, neutrophils and dendritic cells, and these associations were positive in GBM, THCA, THYM and PRAD, but negative in UVM, MESO, LUSC (Figure 6A). Here, AKR1B10 is linked to glioblastoma.